Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > European Asthma Therapeutics Markets
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

European Asthma Therapeutics Markets

Published by Frost & Sullivan
Published July, 2007 Product code 54082
Content info 82 Pages
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Asthma Therapeutics Markets published by Frost & Sullivan in July, 2007. This report consists of 82 Pages and the price starts from US $ 6500.

Introduction

Abstract

This Frost & Sullivan research service titled European Asthma Therapeutics Markets provides key challenges, forecasts and recommendations for the asthma therapeutics market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following markets: short acting beta 2 agonists, inhaled corticosteroids, combination therapies and leukotriene antagonists.

This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Service programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 MARKET OVERVIEW

  • Introduction
    • Disease Characteristics
    • Epidemiology
  • Market Definition and Segmentation
    • Definition
    • Segmentation

2 RESEARCH METHODOLOGY

  • Research Objectives and Scope
    • Research Methodology

3 INDUSTRY CHALLENGES

  • Challenges For The Asthma Therapeutics Market
    • Challenges Faced by the Pharmaceutical Companies

4 EUROPEAN ASTHMA THERAPEUTICS MARKET

  • Overview and Definitions
    • Introduction
    • Market Engineering Measurements Analysis
    • Market Drivers
    • Market Restraints
    • Current Therapeutic Options
    • Future Therapeutic Approaches
    • Current Treatment Guidelines
    • Regulatory Affairs
  • Competitive Analysis
    • Profiles of Key Industry Participants
    • Market Share Analysis

5 FORECASTS FOR THE EUROPEAN ASTHMA THERAPEUTICS MARKET

  • Forecasts
    • Patient Forecasts
    • Market Revenue Forecasts
    • Market Share Analysis By Drug Class
    • Forecasts of Recent Entrants - Xolair

6 PRICING AND REIMBURSEMENT IN EUROPE

  • Factors Affecting Pricing and Reimbursement in Europe
    • Pricing and Reimbursement

7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN ASTHMA THERAPEUTICS MARKET

  • Market Engineering Recommendations
    • Strategic Recommendations

8 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • Key Participants in the Asthma Therapeutics Market

9 DECISION SUPPORT DATABASES

  • DSD Tables
    • DSD 1
    • DSD 2
    • DSD 3
    • DSD 4
Back to Top